229 related articles for article (PubMed ID: 28931195)
1. Hereditary hemorrhagic telangiectasia-laser treatment of epistaxis.
Poje G; Kavanagh MM
Ear Nose Throat J; 2017 Sep; 96(9):E10-E14. PubMed ID: 28931195
[TBL] [Abstract][Full Text] [Related]
2. Laser-Assisted Control of Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review.
Abiri A; Goshtasbi K; Maducdoc M; Sahyouni R; Wang MB; Kuan EC
Lasers Surg Med; 2020 Apr; 52(4):293-300. PubMed ID: 31441079
[TBL] [Abstract][Full Text] [Related]
3. New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia.
Mahoney EJ; Shapshay SM
Am J Rhinol; 2006; 20(1):87-90. PubMed ID: 16539301
[TBL] [Abstract][Full Text] [Related]
4. Comparison of electrosurgical plasma coagulation and potassium-titanyl-phosphate laser photocoagulation for treatment of hereditary hemorrhagic telangiectasia-related epistaxis.
Luk L; Mace JC; Bhandarkar ND; Sautter NB
Int Forum Allergy Rhinol; 2014 Aug; 4(8):640-5. PubMed ID: 24719397
[TBL] [Abstract][Full Text] [Related]
5. Nd:YAG laser treatment of recurrent epistaxis in heredity hemorrhagic telangiectasia.
Velegrakis GA; Prokopakis EP; Papadakis CE; Helidonis ES
J Otolaryngol; 1997 Dec; 26(6):384-6. PubMed ID: 9438937
[TBL] [Abstract][Full Text] [Related]
6. The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis.
Harvey RJ; Kanagalingam J; Lund VJ
Am J Rhinol; 2008; 22(2):182-7. PubMed ID: 18416977
[TBL] [Abstract][Full Text] [Related]
7. Diode laser in the treatment of epistaxis in patients with hereditary haemorrhagic telangiectasia.
Fiorella ML; Lillo L; Fiorella R
Acta Otorhinolaryngol Ital; 2012 Jun; 32(3):164-9. PubMed ID: 22767981
[TBL] [Abstract][Full Text] [Related]
8. In-Office KTP Laser for Treating Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis.
Wu V; Kell E; Faughnan ME; Lee JM
Laryngoscope; 2021 Mar; 131(3):E689-E693. PubMed ID: 32557619
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Hereditary Hemorrhagic Telangiectasia-Related Epistaxis.
Sautter NB; Smith TL
Otolaryngol Clin North Am; 2016 Jun; 49(3):639-54. PubMed ID: 27267016
[TBL] [Abstract][Full Text] [Related]
10. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu).
Hanks JE; Hunter D; Goding GS; Boyer HC
Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220
[TBL] [Abstract][Full Text] [Related]
11. Avastin and diode laser: a combined modality in managing epistaxis in hereditary hemorrhagic telangiectasia.
Marglani OA; Bawazeer NA; Abu Suliman OA
Am J Otolaryngol; 2013; 34(5):603-5. PubMed ID: 23541684
[TBL] [Abstract][Full Text] [Related]
12. Laser photocoagulation in hereditary hemorrhagic telangiectasia.
Parkin JL; Dixon JA
Otolaryngol Head Neck Surg; 1981; 89(2):204-8. PubMed ID: 6787514
[TBL] [Abstract][Full Text] [Related]
13. Correlation of severity of epistaxis with nasal telangiectasias in hereditary hemorrhagic telangiectasia (HHT) patients.
Pagella F; Colombo A; Matti E; Giourgos G; Tinelli C; Olivieri C; Danesino C
Am J Rhinol Allergy; 2009; 23(1):52-8. PubMed ID: 19379613
[TBL] [Abstract][Full Text] [Related]
14. Sinonasal quality of life outcomes following laser treatment of epistaxis related to hereditary hemorrhagic telangiectasia.
Kuan EC; Peng KA; Thompson CF; Suh JD; Wang MB
Lasers Med Sci; 2017 Apr; 32(3):527-531. PubMed ID: 28116537
[TBL] [Abstract][Full Text] [Related]
15. The Young's procedure for severe epistaxis from hereditary hemorrhagic telangiectasia.
Richer SL; Geisthoff UW; Livada N; Ward PD; Johnson L; Mainka A; Henderson KJ; Maune S; White RI; Ross DA
Am J Rhinol Allergy; 2012; 26(5):401-4. PubMed ID: 23168156
[TBL] [Abstract][Full Text] [Related]
16. Combined therapy for epistaxis by hereditary hemorrhagic teleangiectasia: A 3-year follow up study on 45 patients.
Papaspyrou G; Hecker D; Linxweiler M; Schick B; Al Kadah B
J Craniomaxillofac Surg; 2017 Aug; 45(8):1179-1182. PubMed ID: 28615135
[TBL] [Abstract][Full Text] [Related]
17. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia.
Hitchings AE; Lennox PA; Lund VJ; Howard DJ
Am J Rhinol; 2005; 19(1):75-8. PubMed ID: 15794079
[TBL] [Abstract][Full Text] [Related]
18. Frequency of epistaxis and telangiectasia in patients with hereditary hemorrhagic telangiectasia (HHT) in comparison with the general population: Curaçao diagnostic criteria revisited.
McDonald J; Kornish J; Stevenson DA; Hanson-Kahn A; Balch H; James J; Naik H; Whitehead KJ
Genet Med; 2023 Aug; 25(8):100865. PubMed ID: 37125633
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy assessment of current treatment options for epistaxis in HHT.
Dür C; Anschuetz L; Negoias S; Bulut OC; Angelillo-Scherrer A; Caversaccio M
Eur Arch Otorhinolaryngol; 2021 Nov; 278(11):4321-4328. PubMed ID: 33661356
[TBL] [Abstract][Full Text] [Related]
20. Using the KTP/532 laser to control epistaxis in patients with hereditary hemorrhagic telangiectasia.
Vickery CL; Kuhn FA
South Med J; 1996 Jan; 89(1):78-80. PubMed ID: 8545698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
